4th European Biosimilars Conference

As the 4th conference of its kind, the 2016 programme gives a complete 360-degree overview of biosimilar medicines. Participants will leave the conference with a wealth of new information and an expanded network of contacts.

Back to Agenda

Session 3: Biosimilar Medicines in Clinical Use – Case Studies and Real-World Evidence

Session Chair(s)

Arnold Vulto, PharmD, PhD

Em. Professor of Hospital Pharmacy & Practical Therapeutics, Erasmus University Medical Center Rotterdam, Netherlands

This session will focus on the most recent experience related to clinical implementation of biosimilars.

Speaker(s)

Switching Between Reference and Biosimilar Medicines: update on the Nor-Switch Study

Jorgen Jahnsen

Professor, Akershus University Hospital, Norway

Gianluca Trifiro, MD, PhD

Scientific Lead, INSPIRE; Professor, Pharmacology, Diagnostics and Public Health, University of Verona, Italy

Hands-on Experience on Practical Implementation of a Biosimilar Outside of Switching Programme

Marieke Pereboom

Hospital Pharmacist, SAHZ, Netherlands

A nationwide biosimilar switch – data from the Danish Rheumatologic Biobank and DANBIO

Tina Kringelbach

Project Manager, Danish Rheuma Biobank, Denmark

Have an account?